Sanofi
Sanofi engages in the research and development, manufacturing and marketing of pharmaceutical drugs principally in the prescription market, but the firm also develops over-the-counter medication. The company covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis and vaccines (it is the world's largest producer of the latter through its subsidiary Sanofi Pasteur). In 2017, Sanofi's dengue vaccine Dengvaxia garnered controversy because it caused some vaccinated young children to have more cases of severe dengue. The "New York Times" cited criticism for Sanofi's aggressive ad campaign despite the fact that this new vaccine was not completely safe.
Q158205
Sanofi
ORG
Q276099
research and development
Concept
Q12140
pharmaceutical drugs
Concept
Q1154971
over-the-counter medication
Concept
Q11068
cardiovascular
Concept
Q47273
central nervous system
Concept
Q12206
diabetes
Concept
Q11180
internal medicine
Concept
Q162555
oncology
Concept
Q261327
thrombosis
Concept
Q134808
vaccine
Concept
Q688657
Sanofi Pasteur
ORG
2017-01-01T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
2017
DATE
Q158205
Sanofi
ORG
Q158205
Sanofi
ORG
Q1154971
over-the-counter medication
Concept
Q12140
pharmaceutical drugs
Concept
Q134808
vaccine
Concept
Q688657
Sanofi Pasteur
ORG
Q688657
Sanofi Pasteur
ORG
Q158205
Sanofi
ORG